Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
90%
Pharmacokinetics
49%
Infection
49%
Community Pharmacy
47%
Prevalence
46%
Antioxidant
36%
Antidepressant
35%
Antibacterial Activity
32%
Receptor
32%
Phytochemical
30%
Antioxidant Capacity
29%
Anti-Inflammatory Drug
29%
Adverse Event
27%
Antiinfective Agent
27%
Tramadol
27%
Heart Failure with Reduced Ejection Fraction
26%
Cross Sectional Study
26%
Tolerability
26%
Polypharmacy
26%
Cohort Study
26%
Tablet
26%
Randomized Controlled Trial
23%
Beta Adrenergic Receptor Blocking Agent
21%
Malignant Neoplasm
21%
Alginic Acid
20%
Psychotropic Agent
20%
Flucloxacillin
19%
Diseases
18%
Natural Product
18%
All Cause Mortality
17%
Cross-Sectional Study
17%
Cholecalciferol
16%
Nanoparticle
16%
Vitamin D Receptor
16%
Hypnotic
16%
Pharmacotherapy
15%
Methylglyoxal
15%
Lumisterol
15%
7-Dehydrocholesterol
15%
Leptospermum
15%
Chronic Kidney Failure
14%
Prednisolone
14%
Deoxyribonuclease
14%
Antibiotics
14%
Vitamin D
14%
High Performance Liquid Chromatography
14%
Atrial Fibrillation
13%
Anxiolytic
13%
Neoplasm
13%
Fibroblast Growth Factor 2
13%
Mouse Model
13%
Prospective Cohort Study
13%
Statin (Protein)
13%
Pyoderma gangrenosum
13%
Clover
13%
Cholinergic Receptor Blocking Agent
13%
Non Insulin Dependent Diabetes Mellitus
13%
Hospital Pharmacy
13%
Amoxicillin
13%
Cholesterol Side-Chain Cleavage Enzyme
13%
Peppermint
12%
Antimicrobial Agent
11%
Observational Study
11%
Flavoring Agent
11%
Bipolar Disorder
11%
Pleura Effusion
11%
Tissue Plasminogen Activator
11%
Minimum Inhibitory Concentration
10%
Biological Activity
10%
Anticoagulant Agent
10%
Bioavailability
10%
Drug Release
10%
Heart Failure with Preserved Ejection Fraction
9%
Ischemic Heart Disease
9%
Agar
9%
Chitosan
9%
Subcutaneous Injection
9%
Stingless Bee
9%
Flavonoid
8%
Antibiotic Therapy
8%
Apis mellifera
8%
Hydrogen Peroxide
8%
Dipeptidyl Carboxypeptidase Inhibitor
8%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
8%
Eucalypt
8%
1,1 Diphenyl 2 Picrylhydrazyl
8%
Sodium Glucose Cotransporter 2 Inhibitor
8%
Messenger RNA
8%
Clinical Study
8%
Nootropic Agent
8%
Myocardial Disease
8%
Pharmacological Activity
7%
Renin-Angiotensin System Inhibitor
7%
Vaccine
7%
Liver X Receptor
7%
Anemia
7%
O-Desmethyltramadol
7%
Analgesic Agent
7%
Chronic Obstructive Lung Disease
7%
Midazolam
7%
Medicine and Dentistry
Congestive Heart Failure
100%
Medicine
66%
Systematic Review
46%
Anaphylaxis
39%
Lactation
39%
Aged Care
38%
Heart Failure with Reduced Ejection Fraction
37%
Pleural Infection
33%
Health Care Cost
32%
Diabetes
30%
Prevalence
28%
Atrial Fibrillation
27%
Cross Sectional Study
27%
Maturity Onset Diabetes of the Young
26%
Hazard Ratio
26%
Community Pharmacy
25%
Randomized Controlled Trial
25%
General Practitioner
25%
Public Health
22%
Adverse Event
22%
Cohort Analysis
21%
Ejection Fraction
21%
Surveillance System
20%
Teledentistry
19%
COVID-19 Vaccine
19%
Malignant Neoplasm
19%
Deoxyribonuclease
17%
Socioeconomic Status
17%
Health Outcomes
17%
Receptor
17%
Chronic Kidney Disease
16%
Pediatrics
16%
COVID-19
16%
Clinician
15%
Thromboprophylaxis
15%
Amino Terminal Sequence
15%
Primary Health Care
15%
Quality of Life
15%
Pleura Effusion
14%
Vaccine
14%
Polypharmacy
13%
Diabetes Mellitus
13%
Complementary Medicine
13%
Cancer Stem Cell
13%
Cystic Fibrosis
13%
Clinical Feature
13%
Brain Natriuretic Peptide
13%
Health Care
13%
Heart Failure with Preserved Ejection Fraction
12%
Placebo
12%
Diseases
11%
Heart Left Ventricle Ejection Fraction
11%
Physician
11%
Tissue Plasminogen Activator
11%
Food Allergy
10%
Observational Study
10%
Vitamin D Receptor
10%
Checklist
10%
All Cause Mortality
10%
Health Literacy
9%
Medicines Management
9%
Pediatrics Patient
9%
Telehealth
9%
Monoclonal Antibody
8%
Infant Feeding
8%
Statin
8%
Sudden Cardiac Death
8%
Meta-Analysis
8%
Comorbidity
8%
Protocol Compliance
7%
Lung
7%
Risk Stratification
7%
Metabolite
7%
Body Mass Index
7%
Drug Therapy
7%
Ischemic Heart Disease
7%
Household
7%
Parasympatholytic
7%
Hospital Inpatient
7%
Anemia
7%
Titrimetry
7%
Digital Health
7%
Nanoparticle
7%
Patient with Type 2 Diabetes
7%
Vitamin D
7%
Anticoagulant
7%
Beta Adrenergic Receptor Blocking Agent
6%
Clinical Guideline
6%
Dentist
6%
Patient Care
6%
Mental Health
6%
Perioperative Medicine
6%
Global Disease Burden
6%
Wound
6%
Steroid Therapy
6%
Frailty
6%
ACE Inhibitor
6%
Prematurity
6%
Azithromycin
6%
Elective Surgery
6%
Nursing and Health Professions
Systematic Review
73%
Practice Guideline
65%
Aged Care
44%
Health Literacy
44%
Anaphylaxis
39%
Pharmacy
38%
Physician
34%
Polypharmacy
33%
Health Outcomes
31%
Mental Health
30%
Checklist
29%
Deprescribing
28%
Congestive Heart Failure
26%
Health Practitioner
25%
Medication Therapy Management
24%
Occupation (Patient Social Context)
22%
Meta Analysis
21%
Health Care Personnel
21%
General Practitioner
20%
Teledentistry
19%
Primary Medical Care
19%
Prevalence
19%
Health Care
17%
Standard of Practice
15%
Hospital Pharmacist
15%
Cross-Sectional Study
15%
Model of Care
14%
Professional Practice
14%
Pharmacy Student
13%
Eczema
13%
Non Insulin Dependent Diabetes Mellitus
13%
Atrial Fibrillation
13%
Vaccine Efficacy
13%
Vaccine
13%
University Student
13%
Pyoderma gangrenosum
13%
Diseases
12%
General Practice
12%
Odds Ratio
11%
Community Pharmacist
11%
Care Pathway
11%
Quality of Life
11%
Treatment Outcome
11%
CINAHL
11%
Medline
11%
Embase
11%
Cohort Analysis
11%
World Health Organization
10%
Medicines Management
10%
Scopus
10%
Nutrition Policy
10%
Confidence Interval
10%
Beta Adrenergic Receptor Blocking Agent
10%
Self-Efficacy
10%
Hospital
9%
Socioeconomic Status
9%
Hospital Pharmacy
9%
Thematic Analysis
9%
Patient Care
9%
Dipeptidyl Carboxypeptidase Inhibitor
8%
Prednisolone
8%
Emergency Ward
8%
Food Allergy
8%
Infection
8%
Protocol Compliance
8%
Adverse Event
8%
Shared Decision-Making
7%
Infant Feeding
7%
PsycINFO
7%
Hospital Readmission
7%
Anticoagulant Agent
7%
Hospital Inpatient
7%
Shared Care
7%
Malignant Neoplasm
7%
Audio Recording
7%
Pharmacist
6%
Heart Ejection Fraction
6%
Qualitative Content Analysis
6%
Optometry
6%
Practice Gap
6%
Coughing
6%
Holistic Health
6%
Potentially Inappropriate Medication
6%
Eye Disease
6%
Placebo
6%
First Aid
6%
Medication Compliance
6%
Clinical Pathway
6%
Titrimetry
6%
Angiographic Catheter
6%
Wound
6%
Angiotensin Receptor Antagonist
6%
Chronic Kidney Failure
6%
Health Care Utilization
6%
Topical Treatment
6%
Reimbursement
6%
Electronic Health Record
6%
Electronic Prescribing
6%
Tuberculosis
6%
Drug Resistant Tuberculosis
6%